4.8 Article

Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH plus lung cancer stem cells through IGF1R signaling

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Cancer stem cells and EMT in carcinoma

Adrian Biddle et al.

CANCER AND METASTASIS REVIEWS (2012)

Review Oncology

Cancer stem cells: In the line of fire

Malcolm R. Alison et al.

CANCER TREATMENT REVIEWS (2012)

Article Pharmacology & Pharmacy

Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy

James A. McCubrey et al.

CURRENT PHARMACEUTICAL DESIGN (2012)

Article Pharmacology & Pharmacy

Cancer Stem Cells and Novel Targets for Antitumor Strategies

Gerald J. Prud’homme

CURRENT PHARMACEUTICAL DESIGN (2012)

Review Cell & Tissue Engineering

Eyes Wide Open: A Critical Review of Sphere-Formation as an Assay for Stem Cells

Erika Pastrana et al.

CELL STEM CELL (2011)

Article Oncology

A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer

Rosario Perona et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2011)

Article Biochemistry & Molecular Biology

EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment

Yuanjie Hu et al.

MOLECULAR CANCER (2011)

Review Oncology

Lung Cancer Stem Cell: New Insights on Experimental Models and Preclinical Data

Caroline Rivera et al.

JOURNAL OF ONCOLOGY (2011)

Article Oncology

Lung Cancer Stem Cells as a Target for Therapy

Elieser Gorelik et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)

Article Oncology

Cancer Stem Cells and Self-renewal

Catherine Adell O'Brien et al.

CLINICAL CANCER RESEARCH (2010)

Article Biochemistry & Molecular Biology

Lung Cancer: Are we up to the Challenge?

Luca Esposito et al.

CURRENT GENOMICS (2010)

Article Biochemistry & Molecular Biology

EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells

Peter Camaj et al.

BIOLOGICAL CHEMISTRY (2009)

Review Biochemistry & Molecular Biology

Epithelial-Mesenchymal Transitions in Development and Disease

Jean Paul Thiery et al.

Review Biochemistry & Molecular Biology

Fibulins: Multiple roles in matrix structures and tissue functions

S. de Vega et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2009)

Article Biochemistry & Molecular Biology

Aldehyde dehydrogenase activity as a functional marker for lung cancer

Deniz Ucar et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2009)

Article Biochemistry & Molecular Biology

Reversibility and recurrence of IGF-IR-induced mammary tumors

R. A. Jones et al.

ONCOGENE (2009)

Review Pharmacology & Pharmacy

EGFR-targeted therapies in lung cancer: predictors of response and toxicity

Rebecca Suk Heist et al.

PHARMACOGENOMICS (2009)

Article Biochemistry & Molecular Biology

Characterization of a stem cell population in lung cancer A549 cells

Ji-Min Sung et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)

Article Biochemistry & Molecular Biology

The epithelial-mesenchymal transition generates cells with properties of stem cells

Sendurai A. Mani et al.

Review Biochemistry & Molecular Biology

Cancer Stem Cells: How can we Target them?

Ivan Ischenko et al.

CURRENT MEDICINAL CHEMISTRY (2008)

Review Oncology

Insulin and insulin-like growth factor signalling in neoplasia

Michael Pollak

NATURE REVIEWS CANCER (2008)

Article Cell & Tissue Engineering

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Christophe Ginestier et al.

CELL STEM CELL (2007)

Article Anatomy & Morphology

Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions

Bradley W. Doble et al.

CELLS TISSUES ORGANS (2007)

Article Multidisciplinary Sciences

ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines

JA Engelman et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Oncology

The Akt pathway: Molecular targets for anti-cancer drug development

CS Mitsiades et al.

CURRENT CANCER DRUG TARGETS (2004)

Article Multidisciplinary Sciences

A stem cell molecular signature

NB Ivanova et al.

SCIENCE (2002)